Home · Compare

Mayukh Sukhatme vs Stuart A. Arbuckle

💰 How does your salary compare?

See how you rank against the world's top executives — free, instant, SEC-backed data

Mayukh Sukhatme earned $242.5M (2596%) more than Stuart A. Arbuckle in their most recent fiscal years on record.

Mayukh SukhatmeStuart A. Arbuckle

CompanyRoivant SciencesVertex Pharmaceuticals

TitlePresident and Chief Investment OfficerChief Operating Officer

IndustryHealthcareHealthcare

Fiscal YearFY2024FY2025

Total Pay$251.9M$9.3M

Base Salary$550,000—

Stock Awards$170.2M—

Bonus$81.1M$521,486

Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.

← Back to database · Mayukh Sukhatme's full profile · Stuart A. Arbuckle's full profile

ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy